Phase 1bData readout

GB-0895

COPD

GENBGenerate Biomedicines

Expected catalystSeptember 8, 2026Company guidance: Sep 8, 2026

Catalyst overview

Event details

Drug or asset: GB-0895
Development stage: Phase 1b
Event type: Data readout
Indication: COPD

Research summary

What is being tracked?

This catalyst tracks a Phase 1b data readout for GB-0895 in COPD. The expected timing is based on the latest available company guidance and may change.

Development notes

05/07/26:- GB-0895 Ph1b ongoing in COPD to assess safety, PK, and PD activity. 08/06/26:- Ph1b COPD data presentation at ERS 2026 expected Sept 8, 2026.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source